These results provide insight into basic design principles for generating new clinically relevant lead peptides. It also provides an alternative strategy where a peptide and a non-peptide drug can be used in combination to battle increasingly drug-resistant microbes.
International Journal of Antimicrobial Agents, Volume 39, Issue 2, February 2012, Pages 146–152
PLoS ONE 5(12): e14446
Antimalarial, antibacterial and combined rectal formulations are likely to be cost-effective interventions for severe febrile illness in the community.